Recent Press Releases
March 2nd, 2010
U.S. Food and Drug Administration (FDA) Sets 22 March for Oncologic Drugs Advisory Committee (ODAC) Meeting to Review OMAPRO™
February 9th, 2010
Extreme Weather in Washington D.C. has Postponed the FDA’s Oncologic Drugs Advisory Committee Meeting Scheduled for 10 February 2010
December 17th, 2009
ChemGenex Pharmaceuticals Announces Omapro™ to be Reviewed by the FDA’s Oncologic Drugs Advisory Committee
December 14th, 2009
ChemGenex, Hospira, Announce Agreement to License, Develop and Commercialize Leukemia Drug in Europe
December 9th, 2009
Omapro™ Featured During ASH Oral Session
December 7th, 2009
Pivotal Data on ChemGenex’s Omapro™ Highlighted at ASH Press Conference
November 27th, 2009
ChemGenex’s Marketing Authorization Application for Omacetaxine Mepesuccinate Validated by the European Medicines Agency
November 10th, 2009
ChemGenex Announces FDA Accepts NDA for Omapro™ (Omacetaxine Mepesuccinate) and Grants the Filing Priority Review Status
October 28th, 2009